We provide you with 20 years of free, institutional-grade data for VCNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VCNX. Explore the full financial landscape of VCNX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-04-02 | 0001205922 | VCNX | 10-K | Url |
| 2023-09-14 | 0001205922 | VCNX | S-1 | Url |
| 2022-08-15 | 0001205922 | VCNX | 10-Q | Url |
| 2022-05-16 | 0001205922 | VCNX | 10-Q | Url |
| 2022-03-31 | 0001205922 | VCNX | 10-K | Url |
| 2020-05-14 | 0001205922 | VCNX | 10-Q | Url |
| 2020-03-09 | 0001205922 | VCNX | 10-K | Url |
| 2019-11-12 | 0001205922 | VCNX | 10-Q | Url |
| 2019-05-15 | 0001205922 | VCNX | 10-Q | Url |
| 2018-11-13 | 0001205922 | VCNX | 10-Q | Url |
| 2018-08-14 | 0001205922 | VCNX | 10-Q | Url |
Vaccinex, Inc(NASDAQ:VCNX) 
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune diso...
Website: http://www.vaccinex.com
Founded: 2001
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VCNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.